Egrifta

Drug Hypersensitivity

Hypertension

Pregnancy

Breast Neoplasms

Diabetes Mellitus, Type 2

Pulmonary Edema

Hypotension

Myocardial Infarction

Fever

Pain

Urinary Tract Infections

Headache

Pneumonia

Drug-Related Side Effects and Adverse Reactions

Bronchitis

Renal Insufficiency

Urticaria

Drug Overdose

Diarrhea

Carcinoma, Squamous Cell

Death

Hypersensitivity

Asthma

Kidney Failure, Chronic

Arrhythmias, Cardiac

Psychotic Disorders

Musculoskeletal Pain

Diabetes Mellitus

Migraine Disorders

Diverticulitis

Constipation

Abdominal Pain

Depressive Disorder

Hypersensitivity, Immediate

Hyperhidrosis

Dyspepsia

Influenza, Human

Edema

Syncope

Liver Failure

Sinusitis

Vomiting

Nausea

Pancreatitis

Hyperlipoproteinemias

Communicable Diseases

Spasm

Pruritus

Cough

Neck Pain

Respiratory Insufficiency

Fatigue

Kidney Calculi

Diverticulitis, Colonic

Maxillary Sinusitis

Carcinoma, Islet Cell

Neoplasms

Headache Disorders

Flushing

Depressive Disorder, Treatment-Resistant

Dysuria

Carcinoma, Basal Cell

Pituitary Neoplasms

Hyperglycemia

Muscle Weakness

Skin Diseases, Parasitic

Tremor

Craniocerebral Trauma

Back Pain

Arthritis

Contusions

Lithiasis

Gynecomastia

Hypopituitarism

HIV-Associated Lipodystrophy Syndrome

Hyperkinesis

Stomatitis, Aphthous

Hyperlipidemias

Growth Hormone Releasing Factor Analog

tesamorelin 2 MG Injection [Egrifta]

tesamorelin 1 MG Injection [Egrifta]

tesamorelin 2 MG Injection

tesamorelin 1 MG Injection

IGF Type 1 Receptor Interactions

tesamorelin

Growth Substances

Increased GHRH Activity

Increased Growth Hormone Secretion

Dosage	Brand	Image
tesamorelin 1 MG Injection	Generic
tesamorelin 1 MG Injection [Egrifta]	Generic
tesamorelin 2 MG Injection	Generic
tesamorelin 2 MG Injection [Egrifta]	Generic

Tesamorelin

Growth Hormone Releasing Factor Analog

Brands

Tesamorelin Injection

Tesamorelin desired effects:

Tesamorelin drug classes:

Tesamorelin pharmacologic actions:

Tesamorelin mechanism of action: